Hancock Jaffe Laboratories Inc reports results for the quarter ended in June - Earnings Summary

enVVeno Medical

11/08/2021 12:31

* Hancock Jaffe Laboratories Inc  HJLI.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 34 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Hancock Jaffe Laboratories Inc's reported EPS for the quarter
was a loss of 28 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Hancock Jaffe Laboratories Inc shares had fallen by 12.7% this
quarter and lost 30.6% so far this year.
* The company reported a quarterly loss of $2.38 million.
* Wall Street's median 12-month price target for Hancock Jaffe
Laboratories Inc is $26.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 11:31 a.m.  ​All
figures in US dollars unless otherwise stated